期刊文献+

HBeAg阴性与阳性原发性肝癌临床和病毒相关因素分析 被引量:15

A correlation factor analysis of clinical and virological characteristics on HBeAg-negative and HBeAg-positive primary hepatic cancer
在线阅读 下载PDF
导出
摘要 目的:研究HBeAg阴性与HBeAg阳性的原发性肝癌患者临床特点和病毒相关因素的差异,并探讨研究其临床意义.方法:对1356例原发性肝癌患者的门诊及住院病历进行回顾性调查,以HBeAg阴性的原发性肝癌患者为对照组,HBeAg阳性的原发性肝癌患者为试验组.分析两组上消化道出血率、AFP水平、乙型肝炎病毒DNA定量和肝组织病理学指标的差异.结果:HBeAg阴性原发性肝癌996例,占73.4%;HBeAg阳性原发性肝癌360例,占26.6%.HBeAg阴性组合并上消化道出血的比例为22.2%,显著高于HBeAg阳性组的11.9%(χ2=17.70,P<0.01).HBeAg阳性组乙型肝炎病毒DNA定量在各级对数值上均显著高于HBeAg阴性组(χ2=298,P<0.005).HBeAg阴性组肝纤维化分期≥3的比例为46.9%,高于HBeAg阳性组的33.1%(χ2=7.27,P=0.007).AFP水平在两组间无明显差异.结论:HBeAg阴性原发性肝癌肝组织学损害程度重于HBeAg阳性原发性肝癌,更易合并肝性门静脉高压症所致的上消化道出血,预后较差.HBeAg阴性患者更要警惕原发性肝癌的发生. AIM: To investigate the clinical and virological characteristics of HBeAg-negative and HBeAg- positive primary hepatic cancer (PHC), and to explore their clinical significance. METHODS: A total of 1356 out-patient and inpatient PHC cases were retrospectively analyzed. HBeAg-negative cases were taken as control group while HBeAg-positive cases were the test group. The upper alimentary canal bleeding rate, serum AFP values, HBV DNA levels were analyzed between the two groups. RESULTS: Of the 1356 cases, 996 (73.4%) were HBeAg-negative(control group) and 360 (26.6%)were HBeAg-positive (test group). Compared with the test group, there was a significantly higher upper alimentary canal bleeding rate (11.9% vs 22.2%,χ^2 = 17.70, P 〈 0.01), a significantly lower DNA levels (χ^2 = 298, P 〈 0.005) in the control group. And the cases of hepatic fibro- sis staging ≥ 3 were also higher in the control group than in the test group (46.9% vs 33.1%, χ^2 = 7.27, P 〈 0.007). No obvious difference in AFP levels was observed between the control group and the test group. CONCLUSION: Hepatic tissue injury is more serious in HBeAg-negative patients than HBeAg- positive patients, and HBeAg-negative patients have greater tendency of developing portal hypertension-associated upper alimentary canal bleeding with a poor prognosis and HBeAg-neg- ative patients should be warned against primary hepatic cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第32期3696-3699,共4页 World Chinese Journal of Digestology
关键词 原发性肝癌 肝炎E抗原 上消化道出血 DNA 组织学 AFP Primary hepatic cancer Hepatitis B e antigens Upper alimentary canal bleeding DNA Histology AFP
  • 相关文献

参考文献6

二级参考文献60

  • 1解春生,郭海,沙素娟,吴战友,常海民,刘立华.肿瘤标志物对消化系统恶性肿瘤诊断价值的初探[J].世界华人消化杂志,2000,8(z1). 被引量:2
  • 2李明友,黎永新,刘志兰.肝病患者11项实验结果的分析[J].世界华人消化杂志,2000,8(z1). 被引量:2
  • 3庄辉.乙型肝炎流行病学研究进展[J].国外医学(流行病学.传染病学分册),2004,31(3):133-135. 被引量:149
  • 4张青.神经节苷脂与细胞功能的调控[J].国外医学(生理病理科学与临床分册),1994,14(4):207-208. 被引量:1
  • 5Iloeje UH, Yang HI, Su J,et al. Viral load is a strong predictor of hepatocellular carcinoma risk in people chronically infected with hepatitis B virus and with normal serum alanine aminotransferase level: The Risk Evaluation of viral load elevation and associated liver disease/cancer study. Presented at 40th EASL 2005.
  • 6汤钊猷 姚光弼 主编.原发性肝癌[A].姚光弼,主编.临床肝脏病学[C].上海:上海科学技术出版社,2004.621-628.
  • 7Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigens and the risk of hepatocellular carcinoma. N Engl J Med, 2002,347:168-174.
  • 8Chen G, Lin WY, Shen FM, et al. Viral load as a predictor of mortality from hepatocellular carcinoma and chronic liver disease in chronic hepatitis B infection. Presented at 40th EASL 2005.
  • 9Chen CJ, Yang HI, Su J,et al. Serum hepatitis B virus(HBV) DNA is associated with incidence of hepatocellular carcinoma(HCC). Presented at 14th APASL 2004.
  • 10Fukumoto H,Nishio K,Ohta S,et al.Ettect of a chimeric antiganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo[J].Int J Cancer,1999,82 (5):759-764.

共引文献122

同被引文献145

引证文献15

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部